HDAC2 and urinary bladder carcinoma: Collectively, these results demonstrate that HDAC2-mediated delactylation at the K17 site of DHX15 promotes bladder cancer progression, at least in part, by modulating the alternative splicing and downregulating the mature RPL9 transcript.